Mountain View, California-based DNA testing firm 23andMe, Inc. has completed US$115 million series E financing round led by Fidelity Management & Research Company, with participation from new investors including WuXi Healthcare Ventures. Other investors include Casdin Capital, Illumina, New Enterprise Associates, MPM Capital, and Google Ventures, also joined the funding round, according to an announcement. […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.